Riferimenti [2] Si veda IFU Cellistypt® .[3] Jindřich Lahovský, MD. Evaluation of efficacy and safety of medical devices series OKCEL®. Study Report Ref. No AP-SY-1501. Data on file: 18640–033.[4] Based on biocompatibility testing of OKCEL® products in accordance with EN ISO 10993. Data on file:18640-033.[5] Jindřich Lahovský, MD. Závěrečná zpráva laboratorního vyhodnocení vlastností hemostatik na bázi oxidované regenerované a neregenerované celulózy. Study Report Ref. No. AP-SY-1901. Data on file: 18640 – 034.[6] Jindřich Lahovský, MD. Evaluation of efficacy and safety of the medical device OKCEL® S. Study Report Ref. No AP-SY-1701. Data on file: 18640–033.[7] Ing. Iveta Brožková, Ph. D. Department of Biological and Biochemical Sciences at the Faculty of Chemical Technology, University of Pardubice. Final report on testing the antimicrobial activity of the product OKCEL®. Data on file: 18640–034.[8] Lewis KM, Spazierer D, Urban MD, Lin L, Redl H, Goppelt A. Comparis[3] Jindřich Lahovský, MD. Evaluation of efficacy and safety of medical devices series OKCEL®. Study Report Ref. No AP-SY-1501. Data on file: 18640–033.[4] Based on biocompatibility testing of OKCEL® products in accordance with EN ISO 10993. Data on file:18640-033.[5] Jindřich Lahovský, MD. Závěrečná zpráva laboratorního vyhodnocení vlastností hemostatik na bázi oxidované regenerované a neregenerované celulózy. Study Report Ref. No. AP-SY-1901. Data on file: 18640 – 034.[6] Jindřich Lahovský, MD. Evaluation of efficacy and safety of the medical device OKCEL® S. Study Report Ref. No AP-SY-1701. Data on file: 18640–033.[7] Ing. Iveta Brožková, Ph. D. Department of Biological and Biochemical Sciences at the Faculty of Chemical Technology, University of Pardubice. Final report on testing the antimicrobial activity of the product OKCEL®. Data on file: 18640–034.[8] Lewis KM, Spazierer D, Urban MD, Lin L, Redl H, Goppelt A. Comparis